Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.
about
EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitorsMechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors[Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010).A robust, target-driven, cell-based assay for checkpoint kinase 1 inhibitors.Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorCharacterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.The disposition and metabolism of GW695634: a non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS.Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.Inhibition of HIV-1 or bacterial activation of macrophages by products of HIV-1-resistant human cells.Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in Taiwan: a multicenter cohort study.
P2860
Q24606095-1AE93569-A9FD-4464-9253-42AD4698B998Q24652511-BEA2625E-F12A-4A5F-8D96-AA95A540B7F5Q35916271-0241D41B-C46E-4438-9ACB-DBEB5956CB15Q37860335-124B086D-7B99-4148-AEAB-EFA05FF2ADBAQ40129501-24F6B656-B47F-421A-BEAC-55C5C4ECDAAEQ40367975-3910F741-98E4-41AC-A704-F91880667BE6Q42179793-76B89B4F-2C00-4D5F-A2B7-3DE5EF282D17Q43104680-7D9A9F2A-F0F5-4717-B49F-ACFACC1BC9F6Q46269343-40945ACC-1596-41EB-A8FF-1A3B0968E5E9Q53540204-3F3964EE-E9FE-4097-A22A-447B703554B9Q55333264-2B1B9E05-D21E-4CE1-AEDE-866E85D305BE
P2860
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
Anti-human immunodeficiency vi ...... itro selection for resistance.
@nl
type
label
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
Anti-human immunodeficiency vi ...... itro selection for resistance.
@nl
prefLabel
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
Anti-human immunodeficiency vi ...... itro selection for resistance.
@nl
P2093
P2860
P1476
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
P2093
George A Freeman
Jeffrey H Tidwell
Jill R Cowan
Joseph H Chan
Karen R Romines
Lawrence R Boone
Lee T Schaller
Marty H St Clair
Richard J Hazen
Robert G Ferris
P2860
P304
P356
10.1128/AAC.49.11.4465-4473.2005
P407
P577
2005-11-01T00:00:00Z